Table of Content

1 Market Overview of Viral Conjunctivitis Drugs
1.1 Viral Conjunctivitis Drugs Market Overview
1.1.1 Viral Conjunctivitis Drugs Product Scope
1.1.2 Viral Conjunctivitis Drugs Market Status and Outlook
1.2 Global Viral Conjunctivitis Drugs Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Viral Conjunctivitis Drugs Market Size by Region (2024-2034)
1.4 Global Viral Conjunctivitis Drugs Historic Market Size by Region (2024-2024)
1.5 Global Viral Conjunctivitis Drugs Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Viral Conjunctivitis Drugs Market Size (2024-2034)
1.6.1 North America Viral Conjunctivitis Drugs Market Size (2024-2034)
1.6.2 Europe Viral Conjunctivitis Drugs Market Size (2024-2034)
1.6.3 Asia-Pacific Viral Conjunctivitis Drugs Market Size (2024-2034)
1.6.4 Latin America Viral Conjunctivitis Drugs Market Size (2024-2034)
1.6.5 Middle East & Africa Viral Conjunctivitis Drugs Market Size (2024-2034)
2 Viral Conjunctivitis Drugs Market by Type
2.1 Introduction
2.1.1 FST-100
2.1.2 APD-209
2.2 Global Viral Conjunctivitis Drugs Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Viral Conjunctivitis Drugs Historic Market Size by Type (2024-2024)
2.2.2 Global Viral Conjunctivitis Drugs Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Viral Conjunctivitis Drugs Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Viral Conjunctivitis Drugs Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Viral Conjunctivitis Drugs Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Viral Conjunctivitis Drugs Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Viral Conjunctivitis Drugs Revenue Breakdown by Type (2024-2034)
3 Viral Conjunctivitis Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 ASCs
3.1.3 Others
3.2 Global Viral Conjunctivitis Drugs Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Viral Conjunctivitis Drugs Historic Market Size by Application (2024-2024)
3.2.2 Global Viral Conjunctivitis Drugs Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Viral Conjunctivitis Drugs Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Viral Conjunctivitis Drugs Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Viral Conjunctivitis Drugs Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Viral Conjunctivitis Drugs Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Viral Conjunctivitis Drugs Revenue Breakdown by Application (2024-2034)
4 Viral Conjunctivitis Drugs Competition Analysis by Players
4.1 Global Viral Conjunctivitis Drugs Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Conjunctivitis Drugs as of 2022)
4.3 Date of Key Players Enter into Viral Conjunctivitis Drugs Market
4.4 Global Top Players Viral Conjunctivitis Drugs Headquarters and Area Served
4.5 Key Players Viral Conjunctivitis Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Viral Conjunctivitis Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Adenovir Pharma
5.1.1 Adenovir Pharma Profile
5.1.2 Adenovir Pharma Main Business
5.1.3 Adenovir Pharma Viral Conjunctivitis Drugs Products, Services and Solutions
5.1.4 Adenovir Pharma Viral Conjunctivitis Drugs Revenue (US$ Million) & (2024-2024)
5.1.5 Adenovir Pharma Recent Developments
5.2 Allergan
5.2.1 Allergan Profile
5.2.2 Allergan Main Business
5.2.3 Allergan Viral Conjunctivitis Drugs Products, Services and Solutions
5.2.4 Allergan Viral Conjunctivitis Drugs Revenue (US$ Million) & (2024-2024)
5.2.5 Allergan Recent Developments
5.3 NanoViricides
5.3.1 NanoViricides Profile
5.3.2 NanoViricides Main Business
5.3.3 NanoViricides Viral Conjunctivitis Drugs Products, Services and Solutions
5.3.4 NanoViricides Viral Conjunctivitis Drugs Revenue (US$ Million) & (2024-2024)
5.3.5 Takeda Recent Developments
5.4 Takeda
5.4.1 Takeda Profile
5.4.2 Takeda Main Business
5.4.3 Takeda Viral Conjunctivitis Drugs Products, Services and Solutions
5.4.4 Takeda Viral Conjunctivitis Drugs Revenue (US$ Million) & (2024-2024)
5.4.5 Takeda Recent Developments
5.5 NovaBay Pharmaceuticals
5.5.1 NovaBay Pharmaceuticals Profile
5.5.2 NovaBay Pharmaceuticals Main Business
5.5.3 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Products, Services and Solutions
5.5.4 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Revenue (US$ Million) & (2024-2024)
5.5.5 NovaBay Pharmaceuticals Recent Developments
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business
5.6.3 Novartis Viral Conjunctivitis Drugs Products, Services and Solutions
5.6.4 Novartis Viral Conjunctivitis Drugs Revenue (US$ Million) & (2024-2024)
5.6.5 Novartis Recent Developments
5.7 Panoptes Pharma
5.7.1 Panoptes Pharma Profile
5.7.2 Panoptes Pharma Main Business
5.7.3 Panoptes Pharma Viral Conjunctivitis Drugs Products, Services and Solutions
5.7.4 Panoptes Pharma Viral Conjunctivitis Drugs Revenue (US$ Million) & (2024-2024)
5.7.5 Panoptes Pharma Recent Developments
5.8 NicOx
5.8.1 NicOx Profile
5.8.2 NicOx Main Business
5.8.3 NicOx Viral Conjunctivitis Drugs Products, Services and Solutions
5.8.4 NicOx Viral Conjunctivitis Drugs Revenue (US$ Million) & (2024-2024)
5.8.5 NicOx Recent Developments
6 North America
6.1 North America Viral Conjunctivitis Drugs Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Viral Conjunctivitis Drugs Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Viral Conjunctivitis Drugs Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Viral Conjunctivitis Drugs Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Viral Conjunctivitis Drugs Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Viral Conjunctivitis Drugs Market Dynamics
11.1 Viral Conjunctivitis Drugs Industry Trends
11.2 Viral Conjunctivitis Drugs Market Drivers
11.3 Viral Conjunctivitis Drugs Market Challenges
11.4 Viral Conjunctivitis Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Viral Conjunctivitis Drugs Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Viral Conjunctivitis Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Viral Conjunctivitis Drugs Market Size Share by Region (2024-2024)
Table 4. Global Viral Conjunctivitis Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Viral Conjunctivitis Drugs Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Viral Conjunctivitis Drugs Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Viral Conjunctivitis Drugs Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Viral Conjunctivitis Drugs Revenue Market Share by Type (2024-2024)
Table 9. Global Viral Conjunctivitis Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Viral Conjunctivitis Drugs Revenue Market Share by Type (2024-2034)
Table 11. North America Viral Conjunctivitis Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Viral Conjunctivitis Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Viral Conjunctivitis Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Viral Conjunctivitis Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Viral Conjunctivitis Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Viral Conjunctivitis Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Viral Conjunctivitis Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Viral Conjunctivitis Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Viral Conjunctivitis Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Viral Conjunctivitis Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Viral Conjunctivitis Drugs Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Viral Conjunctivitis Drugs Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Viral Conjunctivitis Drugs Revenue Market Share by Application (2024-2024)
Table 24. Global Viral Conjunctivitis Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Viral Conjunctivitis Drugs Revenue Market Share by Application (2024-2034)
Table 26. North America Viral Conjunctivitis Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Viral Conjunctivitis Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Viral Conjunctivitis Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Viral Conjunctivitis Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Viral Conjunctivitis Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Viral Conjunctivitis Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Viral Conjunctivitis Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Viral Conjunctivitis Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Viral Conjunctivitis Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Viral Conjunctivitis Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Viral Conjunctivitis Drugs Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Viral Conjunctivitis Drugs Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Conjunctivitis Drugs as of 2022)
Table 39. Date of Key Players Enter into Viral Conjunctivitis Drugs Market
Table 40. Global Viral Conjunctivitis Drugs Key Players Headquarters and Area Served
Table 41. Viral Conjunctivitis Drugs Product Solution and Service
Table 42. Global Viral Conjunctivitis Drugs Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Adenovir Pharma Basic Information List
Table 45. Adenovir Pharma Description and Business Overview
Table 46. Adenovir Pharma Viral Conjunctivitis Drugs Products, Services and Solutions
Table 47. Revenue (US$ Million) in Viral Conjunctivitis Drugs Business of Adenovir Pharma (2024-2024)
Table 48. Adenovir Pharma Recent Developments
Table 49. Allergan Basic Information List
Table 50. Allergan Description and Business Overview
Table 51. Allergan Viral Conjunctivitis Drugs Products, Services and Solutions
Table 52. Revenue (US$ Million) in Viral Conjunctivitis Drugs Business of Allergan (2024-2024)
Table 53. Allergan Recent Developments
Table 54. NanoViricides Basic Information List
Table 55. NanoViricides Description and Business Overview
Table 56. NanoViricides Viral Conjunctivitis Drugs Products, Services and Solutions
Table 57. Revenue (US$ Million) in Viral Conjunctivitis Drugs Business of NanoViricides (2024-2024)
Table 58. NanoViricides Recent Developments
Table 59. Takeda Basic Information List
Table 60. Takeda Description and Business Overview
Table 61. Takeda Viral Conjunctivitis Drugs Products, Services and Solutions
Table 62. Revenue (US$ Million) in Viral Conjunctivitis Drugs Business of Takeda (2024-2024)
Table 63. Takeda Recent Developments
Table 64. NovaBay Pharmaceuticals Basic Information List
Table 65. NovaBay Pharmaceuticals Description and Business Overview
Table 66. NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Products, Services and Solutions
Table 67. Revenue (US$ Million) in Viral Conjunctivitis Drugs Business of NovaBay Pharmaceuticals (2024-2024)
Table 68. NovaBay Pharmaceuticals Recent Developments
Table 69. Novartis Basic Information List
Table 70. Novartis Description and Business Overview
Table 71. Novartis Viral Conjunctivitis Drugs Products, Services and Solutions
Table 72. Revenue (US$ Million) in Viral Conjunctivitis Drugs Business of Novartis (2024-2024)
Table 73. Novartis Recent Developments
Table 74. Panoptes Pharma Basic Information List
Table 75. Panoptes Pharma Description and Business Overview
Table 76. Panoptes Pharma Viral Conjunctivitis Drugs Products, Services and Solutions
Table 77. Revenue (US$ Million) in Viral Conjunctivitis Drugs Business of Panoptes Pharma (2024-2024)
Table 78. Panoptes Pharma Recent Developments
Table 79. NicOx Basic Information List
Table 80. NicOx Description and Business Overview
Table 81. NicOx Viral Conjunctivitis Drugs Products, Services and Solutions
Table 82. Revenue (US$ Million) in Viral Conjunctivitis Drugs Business of NicOx (2024-2024)
Table 83. NicOx Recent Developments
Table 84. North America Viral Conjunctivitis Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 85. North America Viral Conjunctivitis Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 86. Europe Viral Conjunctivitis Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 87. Europe Viral Conjunctivitis Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 88. Asia-Pacific Viral Conjunctivitis Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 89. Asia-Pacific Viral Conjunctivitis Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 90. Asia-Pacific Viral Conjunctivitis Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Viral Conjunctivitis Drugs Market Share by Region (2024-2024)
Table 92. Asia-Pacific Viral Conjunctivitis Drugs Market Share by Region (2024-2034)
Table 93. Latin America Viral Conjunctivitis Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 94. Latin America Viral Conjunctivitis Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 95. Latin America Viral Conjunctivitis Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 96. Middle East & Africa Viral Conjunctivitis Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 97. Middle East & Africa Viral Conjunctivitis Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 98. Middle East & Africa Viral Conjunctivitis Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 99. Viral Conjunctivitis Drugs Market Trends
Table 100. Viral Conjunctivitis Drugs Market Drivers
Table 101. Viral Conjunctivitis Drugs Market Challenges
Table 102. Viral Conjunctivitis Drugs Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Conjunctivitis Drugs Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Viral Conjunctivitis Drugs Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Viral Conjunctivitis Drugs Market Share by Regions: 2022 VS 2034
Figure 4. Global Viral Conjunctivitis Drugs Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Viral Conjunctivitis Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Viral Conjunctivitis Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Viral Conjunctivitis Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Viral Conjunctivitis Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Viral Conjunctivitis Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of FST-100
Figure 11. Global FST-100 Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of APD-209
Figure 13. Global APD-209 Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Global Viral Conjunctivitis Drugs Market Size Share by Type: 2022 & 2034
Figure 15. North America Viral Conjunctivitis Drugs Revenue Market Share by Type (2024-2034)
Figure 16. Europe Viral Conjunctivitis Drugs Revenue Market Share by Type (2024-2034)
Figure 17. Asia-Pacific Viral Conjunctivitis Drugs Revenue Market Share by Type (2024-2034)
Figure 18. Latin America Viral Conjunctivitis Drugs Revenue Market Share by Type (2024-2034)
Figure 19. Middle East and Africa Viral Conjunctivitis Drugs Revenue Market Share by Type (2024-2034)
Figure 20. Hospitals Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 21. ASCs Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Global Viral Conjunctivitis Drugs Market Size Share by Application: 2022 & 2034
Figure 24. North America Viral Conjunctivitis Drugs Revenue Market Share by Application (2024-2034)
Figure 25. Europe Viral Conjunctivitis Drugs Revenue Market Share by Application (2024-2034)
Figure 26. Asia-Pacific Viral Conjunctivitis Drugs Revenue Market Share by Application (2024-2034)
Figure 27. Latin America Viral Conjunctivitis Drugs Revenue Market Share by Application (2024-2034)
Figure 28. Middle East and Africa Viral Conjunctivitis Drugs Revenue Market Share by Application (2024-2034)
Figure 29. Viral Conjunctivitis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 30. Global Top 5 and Top 10 Players Viral Conjunctivitis Drugs Market Share in 2022
Figure 31. North America Viral Conjunctivitis Drugs Market Share by Country (2024-2034)
Figure 32. U.S. Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 33. Canada Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 34. Germany Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 35. France Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 36. U.K. Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 37. Italy Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 38. Russia Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 39. Nordic Countries Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 40. Asia-Pacific Viral Conjunctivitis Drugs Market Share by Region (2024-2034)
Figure 41. China Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 42. Japan Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 43. South Korea Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 44. Southeast Asia Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 45. India Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 46. Australia Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 47. Latin America Viral Conjunctivitis Drugs Market Share by Country (2024-2034)
Figure 48. Mexico Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 49. Brazil Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 50. Middle East & Africa Viral Conjunctivitis Drugs Market Share by Country (2024-2034)
Figure 51. Turkey Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 52. Saudi Arabia Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 53. UAE Viral Conjunctivitis Drugs Market Size (2024-2034) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report